Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P T THOMAS

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
AJNR. American Journal of Neuroradiology|July 4, 2020
In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTIV Preethish-Kumar, A Shah, M Kumar, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1988
Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in miceM I Luster, A E Munson, P T Thomas, et al.
Human & Experimental Toxicology|August 3, 2000
Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?L E Black, J D Green, J Rener, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
AJNR. American Journal of Neuroradiology|July 4, 2020
In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTIV Preethish-Kumar, A Shah, M Kumar, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1988
Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in miceM I Luster, A E Munson, P T Thomas, et al.
Human & Experimental Toxicology|August 3, 2000
Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?L E Black, J D Green, J Rener, et al.
Pageof 6